Revolution Medicines, Inc. RVMD Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -202.1%-48.7pp | -153.4%+0.9pp | -154.3%-8.0pp | -146.3%-32.0pp | |
| Return on invested capital | -247.5%-26.1pp | -221.4%+8.9pp | -230.3%-48.9pp | -181.4%-35.6pp | |
| Efficiency | |||||
| Asset turnover | 0×0.0× | 0×-0.1× | 0.1×0.0× | 0.2×-0.1× | |
| Liquidity | |||||
| Current ratio | 40.4×-21.9× | 62.3×+10.9× | 51.4×+14.6× | 36.8×-15.4× | |
| Leverage | |||||
| Debt-to-equity | 0.3×+0.1× | 0.2×0.0× | 0.3×-0.2× | 0.4×+0.2× | |
| Per Share | |||||
| Book value per share | $37.96-12.1% | $43.17+1.4% | $42.56+38.7% | $30.69-16.0% | |
| Valuation | |||||
| Market capitalization | $38.16B+39.4% | $27.37B+122% | $12.31B+65.7% | $7.43B-22.6% | |
| Price / book | 22.1×+6.6× | 15.4×+4.0× | 11.4×-1.0× | 12.4×-1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.